Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Fair Value Measurements (Tables)

Note 5 - Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2016

Notes Tables

Fair Value, by Balance Sheet Grouping [Table Text Block]

		As of September 30, 2016								Fair Value Measurements
		Carrying				Fair				As of September 30, 2016
		Amount				Value				Level 1				Level 2				Level 3
Assets:
Cash and cash equivalents:
Cash		$	1,693			$	1,693			$	1,693			$	-			$	-
Money market funds			-				-				-				-				-
		$	1,693			$	1,693			$	1,693			$	-			$	-
Marketable securities:
U.S. Treasury securities		$	-			$	-			$	-			$	-			$	-
Liabilities:
Contingent consideration:
Asuragen		$	3,247			$	3,247			$	-			$	-			$	3,247
RedPath			14,653				14,653				-				-				14,653
		$	17,900			$	17,900			$	-			$	-			$	17,900

		As of December 31, 2015								Fair Value Measurements
		Carrying				Fair				As of December 31, 2015
		Amount				Value				Level 1				Level 2					Level 3
Assets:
Cash and cash equivalents:
Cash		$	7,534			$	7,534			$	7,534			$	-				$	-
Money market funds			776				776				776				-					-
		$	8,310			$	8,310			$	8,310			$	-				$	-
Marketable securities:
Money market funds		$	48			$	48			$	48			$	-				$	-
Mutual funds			58				58				58				-					-
U.S. Treasury securities			1,115				1,115				1,115				-					-
Government agency securities			131				131				131				-					-
		$	1,352			$	1,352			$	1,352			$	-				$	-
Liabilities:
Contingent consideration:
Asuragen		$	4,628			$	4,628			$	-			$	-				$	4,628
RedPath			13,921				13,921				-				-					13,921
		$	18,549			$	18,549			$	-			$	-				$	18,549

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

		2016
														Adjustments
		January 1,				Payments				Accretion				to Fair Value				September 30,
Asuragen		$	4,628			$	(450	)		$	243			$	(1,174	)		$	3,247
Redpath			13,921				-				732				-				14,653
		$	18,549			$	(450	)		$	975			$	(1,174	)		$	17,900